Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis.
Sodani P, Mucci L, Girolimetti R, Tedesco S, Monaco F, Campanozzi D, Brunori M, Maltoni S, Bedetta S, Di Carlo AM, Candoli P, Mancini M, Rebonato A, D'Adamo F, Capalbo M, Frausini G. Sodani P, et al. Among authors: frausini g. Respir Med Case Rep. 2020 Jun 27;31:101115. doi: 10.1016/j.rmcr.2020.101115. eCollection 2020. Respir Med Case Rep. 2020. PMID: 32670785 Free PMC article.
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients.
Mattioli M, Benfaremo D, Mancini M, Mucci L, Mainquà P, Polenta A, Baldini PM, Fulgenzi F, Dennetta D, Bedetta S, Gasperoni L, Caraffa A, Frausini G. Mattioli M, et al. Among authors: frausini g. J Thromb Thrombolysis. 2021 Feb;51(2):286-292. doi: 10.1007/s11239-020-02243-z. J Thromb Thrombolysis. 2021. PMID: 32794132 Free PMC article.
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.
Cantini F, Niccoli L, Nannini C, Matarrese D, Natale MED, Lotti P, Aquilini D, Landini G, Cimolato B, Pietro MAD, Trezzi M, Stobbione P, Frausini G, Navarra A, Nicastri E, Sotgiu G, Goletti D. Cantini F, et al. Among authors: frausini g. J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.06.052. Epub 2020 Jun 24. J Infect. 2020. PMID: 32592703 Free PMC article.
Tocilizumab in COVID-19 interstitial pneumonia.
Pomponio G, Ferrarini A, Bonifazi M, Moretti M, Salvi A, Giacometti A, Tavio M, Titolo G, Morbidoni L, Frausini G, Onesta M, Amico D, Rocchi MLB, Menzo S, Zuccatosta L, Mei F, Menditto V, Svegliati S, Donati A, D'Errico MM, Pavani M, Gabrielli A. Pomponio G, et al. Among authors: frausini g. J Intern Med. 2021 May;289(5):738-746. doi: 10.1111/joim.13231. Epub 2021 Jan 29. J Intern Med. 2021. PMID: 33511686 Free PMC article.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases.
Benfaremo D, Luchetti MM, Di Carlo M, Laganà B, Picchianti-Diamanti A, Carubbi F, Pica R, Chimenti MS, Lorenzetti R, Scolieri P, Bruzzese V, Benedetti A, Ramonda R, Giacomelli R, Salaffi F, Gabrielli A; GRADES-IBD Study Group. Benfaremo D, et al. J Rheumatol. 2021 Feb;48(2):179-187. doi: 10.3899/jrheum.200364. Epub 2020 Jul 15. J Rheumatol. 2021. PMID: 32669448
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
[The treatment of refractory hyperlipoproteinemias].
Barone A, Ansuini R, Francolini G, Frausini G, Pupita F. Barone A, et al. Among authors: frausini g. Clin Ter. 1990 Oct 15;135(1):31-6. Clin Ter. 1990. PMID: 2149540 Italian.
26 results